1.Ferencz, C, Rubin, JD, McCarter, RJ, et al. . Congenital heart disease: prevalence at livebirth. The Baltimore-Washington infant study. Am J Epidemiol 1985; 121: 31–36.
2.Meberg, A, Otterstad, JE, Frøland, G, Lindberg, H, Sørland, SJ. Outcome of congenital heart defects-a population-based study. Acta Paediatr 2000; 89: 1344–1351.
3.Cuneo, BF, Curran, LF, Davis, N, Elrad, H. Trends in prenatal diagnosis of critical cardiac defects in an integrated obstetric and pediatric cardiac imaging center. J Perinatol 2004; 24: 674–678.
4.Bonnet, D, Coltri, A, Butera, G, et al. . Detection of transposition of the great arteries in fetuses reduces neonatal morbidity and mortality. Circulation 1999; 99: 916–918.
5.Tworetzky, W, McElhinney, DB, Reddy, VM, Brook, MM, Hanley, FL, Silverman, NH. Improved surgical outcome after fetal diagnosis of hypoplastic left heart syndrome. Circulation 2001; 103: 1269–1273.
6.Franklin, O, Burch, M, Manning, N, Sleeman, K, Gould, S, Archer, N. Prenatal diagnosis of coarctation of the aorta improves survival and reduces morbidity. Heart 2002; 87: 67–69.
7.International Society of Ultrasound in Obstetrics and Gynecology. Cardiac screening guidelines of the fetus: guidelines performing the ‘basicand extended basic’ scan. Ultrasound Obstet Gynecol 2006; 27: 107–113.
8.International Society of Ultrasound in Obstetrics and Gynecology. ISUOG consensus statement: what constitutes a fetal echocardiogram? Ultrasound Obstet Gynecol 2008; 32: 239–242.
9.Vogel, M, Sharland, GK, McElhinney, DB, et al. . Prevalence of increased nuchal translucency in fetuses with congenital heart disease and a normal karyotype. Cardiol Young 2009; 19: 441–445.
10.Rasiah, SV, Publicover, M, Ewer, AK, Khan, KS, Kilby, MD, Zamora, J. A systematic review of the accuracy of first-trimester ultrasound examination for detecting major congenital heart disease. Ultrasound Obstet Gynecol 2006; 28: 5–7.
11.Gembruch, U, Knöpfle, G, Chatterjee, M, Bald, R, Hansmann, M. First-trimester diagnosis of congenital heart disease by two-dimensional and Doppler echocardiography. Obstet Gynecol 1990; 75: 496–498.
12.Gembruch, U, Knöpfle, G, Bald, R, Hansmann, M. Early diagnosis of fetal congenital heart disease by transvaginal echocardiography. Ultrasound Obstet Gynecol 1993; 3: 310–317.
13.Bronshtein, M, Zimmer, EZ, Milo, S, Ho, SY, Lorber, A, Gerlis, LM. Fetal cardiac abnormalities detected by transvaginal sonography at 12–16 weeks’ gestation. Obstet Gynecol 1991; 78: 374–378.
14.Pandya, PP, Snijders, RJM, Johnson, SP, De Lourdes Brizot, M, Nicolaides, KH. Screening for fetal trisomies by maternal age and fetal nuchal translucency thickness at 10 to 14 weeks of gestation. Br J Obstet Gynaecol 1995; 102: 957–962.
15.Smrcek, JM, Berg, C, Geipel, A, et al. . Detection rate of early fetal echocardiography and in utero development of congenital heart defects. J Ultrasound Med 2006; 25: 187–196.
16.Gembruch, U. Prenatal diagnosis of congenital heart disease. Prenat Diagn 1997; 17: 1283–1297.
17.Yagel, S, Cohen, S, Achiron, R. Examination of the fetal heart by five short-axis views: a proposed screening method for comprehensive cardiac evaluation. Ultrasound Obstet Gynecol 2001; 17: 367–369.
18.Yagel, S, Weissman, A, Rotstein, Z, et al. . Congenital heart defects. Natural course and in utero development. Circulation 1997; 96: 550–555.
19.Allan, LD, Sharland, G, Tynan, MJ. The natural history of the hypoplastic heart syndrome. Int J Cardiol 1989; 25: 341–343.
20.Allan, LD, Crawford, DC, Tynan, M. Evolution of coarctation of the aorta in intrauterine life. Br Heart J 1984; 52: 471–473.
21.Allan, LD. Development of congenital lesions in mid- or late gestation. Int J Cardiol 1988; 19: 361–362.
22.Axt-Fliedner, R, Kreiselmaier, P, Schwarze, A, Krapp, M, Gembruch, U. Development of hypoplastic left heart syndrome after diagnosis of aortic stenosis in the first trimester by early echocardiography. Ultrasound Obstet Gynecol 2006; 28: 106–109.
23.Axt-Fliedner, R, Hartge, D, Krapp, M, et al. . Course and outcome of fetuses suspected of having coarctation of the aorta during gestation. Ultraschall Med 2009; 30: 269–276.
24.Head, CE, Jowett, VC, Sharland, GK, Simpson, JM. Timing of presentation and postnatal outcome of infants suspected of having coarctation of the aorta during fetal life. Heart 2005; 91: 1070–1074.
25.Marasini, M, DeCaro, E, Pongiglione, G, Ribaldone, D, Caponetto, S. Left heart obstructive disease: changes in the echocardiographic appearance during pregnancy. J Clin Ultrasound 1993; 21: 65–68.
26.Simpson, JM, Sharland, GK. Natural history and outcome of aortic stenosis diagnosed prenatally. Heart 1997; 77: 205–210.
27.Hornberger, LK, Sanders, SP, Rein, AJJT, Spevak, PJ, Parness, IA, Colan, SD. Left heart obstructive lesions and left ventricular growth in the mid-trimester fetus. A longitudinal study. Circulation 1995; 92: 1531–1538.
28.Fishman, NH, Hof, RB, Rudolph, AM, Heymann, MA. Models of congenital heart disease in fetal lambs. Circulation 1978; 58: 354–364.
29.Hornberger, LK, Sahn, DJ, Kleinman, CS, Copel, J, Silverman, NH. Antenatal diagnosis of coarctation of the aorta: a multicenter experience. J Am Coll Cardiol 1994; 23: 417–423.
30.Hornberger, LK, Sanders, SP, Sahn, DJ, et al. . In utero pulmonary artery and aortic growth and potential for progression of pulmonary outflow tract obstruction in tetralogy of Fallot. J Am Coll Cardiol 1995; 25: 739–745.
31.Smrcek, JM, Berg, C, Geipel, A, Fimmers, R, Diedrich, K, Gembruch, U. Early fetal echocardiography: heart biometry and visualization of cardiac structures between 10 and 15 weeks’ gestation. J Ultrasound Med 2006; 25: 173–182.
32.Hyett, JA, Perdu, M, Sharland, GK, Snijders, RS, Nicolaides, KH. Increased nuchal translucency at 10–14 weeks of gestation as a marker for major congenital heart defects. Ultrasound Obstet Gynecol 1997; 10: 242–246.
33.Makrydimas, G, Sotiriadis, A, Huggon, IC, et al. . Nuchal translucency and fetal cardiac defects: a pooled analysis of major fetal echocardiography centers. Am J Obstet Gynecol 2005; 192: 89–95.
34.Mavrides, E, Cobian-Sanchez, F, Tekay, A, et al. . Limitations of using first-trimester nuchal translucency measurement in routine screening for major congenital heart defects. Ultrasound Obstet Gynecol 2001; 17: 106–110.
35.Matias, A, Gomes, C, Flack, N, Montenegro, N, Nicolaides, KH. Screening for chromosomal abnormalities at 10–14 weeks: the role of ductus venosus blood flow. Ultrasound Obstet Gynecol 1998; 12: 380–384.
36.Matias, A, Huggon, I, Areias, JC, Montenegro, N, Nicolaides, KH. Cardiac defects in chromosomally normal fetuses with abnormal ductus venosus blood flow at 10–14 weeks. Ultrasound Obstet Gynecol 1999; 14: 307–310.